(Total Views: 308)
Posted On: 04/16/2021 1:57:42 PM
Post# of 22464
Agree, and day traders who also want the stock to drop so they can pick up more. They're the ones who keep repeating their negativity. They know QMC's working to uplist and the days between PR drift down. It has nothing to do with the company, only market tendencies. The company has had success in business without regular SEC reports in it's deal with Innova. The SEC reports will probably show some revenue and that will move the stock, but I have stated a half dozen events IMO that could move the stock toward uplisting and off the OTC and they are just as likely to happen prior to the SEC reports as after.
I see this week's PR as a submission to the FDA of a study of the event in France that took two months to complete. I see that strengthening the case for approval of the EUA. I see the CITI cohort probably getting bigger and longer maybe with new tests to get more approvals rather than just one, IMO.
I see the lack of FDA approvals on all test manufacturers as a problem with the FDA rigidity in a pandemic, not with Innova and QMCH.
People trading on the stock are traders. GLTU. The rest of us wiil hold on because we know what we own, as Mikeo said.
I believe when good news comes all the traders won't be able to buy shares anywhere near current. Penny foolish, pound wise! The goal is uplisting.
The funniest are those who make a personal appeal, "Steve, do something" like they're Emu with very tiny brains who think the entire Ecosystem that "Steve" built, and which created so much value that Innova wanted it badly enough to give an offer Squires would accept, they think it's nothing. Emus are a joke character in weak commercials for lousy insurance companies.
"According to the stock platform Etoro, they found that a whopping 80% of day traders lose money over the course of a year with the median loss of -36.30%! It's no surprise more than 75% of all day traders end up quitting within just two years."
Why 80% of Day Traders Lose Money | by Mark Lyck | Medium
I see this week's PR as a submission to the FDA of a study of the event in France that took two months to complete. I see that strengthening the case for approval of the EUA. I see the CITI cohort probably getting bigger and longer maybe with new tests to get more approvals rather than just one, IMO.
I see the lack of FDA approvals on all test manufacturers as a problem with the FDA rigidity in a pandemic, not with Innova and QMCH.
People trading on the stock are traders. GLTU. The rest of us wiil hold on because we know what we own, as Mikeo said.
I believe when good news comes all the traders won't be able to buy shares anywhere near current. Penny foolish, pound wise! The goal is uplisting.
The funniest are those who make a personal appeal, "Steve, do something" like they're Emu with very tiny brains who think the entire Ecosystem that "Steve" built, and which created so much value that Innova wanted it badly enough to give an offer Squires would accept, they think it's nothing. Emus are a joke character in weak commercials for lousy insurance companies.
"According to the stock platform Etoro, they found that a whopping 80% of day traders lose money over the course of a year with the median loss of -36.30%! It's no surprise more than 75% of all day traders end up quitting within just two years."
Why 80% of Day Traders Lose Money | by Mark Lyck | Medium


Scroll down for more posts ▼